Prevalence and profile of patients on antipsychotics in a hospital in southern Brazil

  • André Souza e Silva Universidade do Sul de Santa Catarina
  • Fernanda Emy Inumaru Universidade do Sul de Santa Catarina
  • Rafael Vidor Universidade do Sul de Santa Catarina
  • André Luciano Manoel Universidade do Sul de Santa Catarina
  • Thamy dos Santos Universidade do Sul de Santa Catarina
  • Ana Carolina Carvalho Universidade do Sul de Santa Catarina
  • Daisson José Trevisol Universidade do Sul de Santa Catarina
Keywords: antipsychotics, haloperidol, mental disorders, anxiety.


Aims: To evaluate the prevalence and the profile of inpatients prescribed antipsychotics.

Methods: This was a cross-sectional study which evaluated patients admitted to Hospital Nossa Senhora da Conceição (HNSC), in Tubarão, State of Santa Catarina, Brazil, in 2013, who were prescribed antipsychotic drugs. All the data were collected from electronic medical records. Patients were evaluated according to their sociodemographic characteristics, type of antipsychotic drug prescribed, and clinical diagnosis (ICD 10).

Results: Out of 125,670 patients admitted to HNSC in 2013, 1,559 received some kind of antipsychotic. The mean age of the patients was 50.34 years (SD=22.89). There was no variation in the prevalence of antipsychotic drug prescription between male and female patients, but the frequency of these prescriptions increased with age. Conventional antipsychotics were the most commonly prescribed ones, among which haloperidol was prescribed to 852 (54.7%) patients. Among the major diagnoses, anxiety disorders were the most prevalent ones, detected in 131 (6.3%) patients. Considering only the diagnoses of mental or behavioral disorders and including secondary diagnoses, anxiety disorders were observed in 233 (14.9%) patients. A total of 470 (30.1%) patients on antipsychotics had been diagnosed at least once with mental or behavioral disorders.

Conclusions: The prevalence of antipsychotic drug use was 1.24% among the inpatients, and haloperidol was the most widely prescribed drug. The diagnosis of anxiety disorders was the most frequent one, but most patients who received antipsychotics had not been diagnosed with any psychiatric disorder, and eventually received them for other reasons.


Download data is not yet available.


World Health Organization. WHO model list of Essential Medicines 19th Ed [Internet]. Geneva; 2015. [cited 2015 May]. Available from:

Costa KS, Barros MBA, Franscisco PMSB, César CLG, Goldbaum M, Carandina L. Utilização de medicamentos e fatores associados: um estudo de base populacional no Município de Campinas, São Paulo, Brasil. Cad Saúde Pública. 2011;27(4):649-58.

Lambrey S, Falissard B, Martin-Barrero M, Bonnefoy C, Quilici G, Rosier A, et al. Effectiveness of clozapine for the treatment of aggression in an adolescent with autistic disorder. J Child Adolesc Psychopharmacol. 2010;20(1):79-80.

Faculdade de Medicina da Universidade de São Paulo. Interações medicamentosas em psiquiatria [Internet]. São Paulo; 2014. [cited 2015 May]. Available from:

Page VJ, Ely EW, Gates S, Zhao XB, Alce T, Shintani A, et al. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2013;1(7):515-23.

Komossa K, Rummel-Kluge C, Schwarz S, Schmid F, Hunger H, Kissling W, et al. Risperidone versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev. 2011;19;(1):CD006626.

Divac N, Prostran M, Jakovcevski, Cerovac N. Second-generation antipsychotics and extrapyramidal adverse effects. Biomed Res Int. 2014;6(5)63-70.

Meltzer HY, Matsubara S, Lee JC. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther. 1989;251(1):238-46.

Khasawneh FT, Shankar GS. Minimizing cardiovascular adverse effects of atypical antipsychotic drugs in patients with schizophrenia. Cardiol Res Pract. 2014;2(7)30-60.

Pereira MO, Souza JM, Costa AM, Vargas D, Oliveira MAF, Moura WN. Perfil dos usuários de serviços de Saúde Mental do município de Lorena – São Paulo. Acta Paul Enferm. 2012;25(1):48-54.

Pincus HA, Tanielian TL, Marcus SC, Olfson M, Zarin DA, Thompson J, et al. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA. 1998;279(7):526-31.

Gonçalves DP, Silva IV, Rangel LB, Rezende LC. Prescription of psychoactive drugs in patients attended by the SUS at Manhuaçu – MG (Brazil). Pharmacy Practice. 2011;9(4):200-6.

Agency for Healthcare Research and Quality (US). Future Research Needs for First- and Second-Generation Antipsychotics for Children and Young Adults [Internet]. Rockville; 2012 [cited 2015 May]. Available from:

Machado FB, Gomes MF, Junior SEM, Mella EAC. Determinação dos antipsicóticos utilizados no hospital municipal de Maringá – Paraná. Semina Cienc Biol Saúde. 2009;30(1):77-82.

Powney MJ1, Adams CE, Jones H. Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). Cochrane Database Syst Rev. 2012; 14;11:CD009377.

Diógenes AR, Rodrigues FC, Xavier CA, Guerra GC, Alves MSCF, Ferreira AA. Análise da relação custo e consumo dos antipsicóticos típicos e atípicos: implicações para a saúde pública. Rev Ciênc Méd Biol. 2007;6(3):275-81.

Horn M, Vaiva G, Dumais A. Drug management of agitation in emergency departments: theoretical recommendations and studies of practices. Presse Med. 2015 Jan;44(1):20-6.

Nieto RR, Silva HI. Prescripción de antipsicóticos atípicos en pacientes hospitalizados de la Clínica Psiquiátrica Universitaria. Rev Chil Neuro-psiquiat. 2008;46(1):16-24.

Shirama FH, Miasso AI. Consumo de psicofármacos por pacientes de clínicas médica e cirúrgica de um hospital geral. Rev Latino-Am Enfermagem. 2013;21(4):1-8.

Arilla JA, Fernández ME, Vi-uales E, Lozano I. Politerapia antipsicótica en una unidad de hospitalización psiquiátrica. Rev Psiquiatr Salud Ment (Barc). 2010;3(3):90-6.

Baldaçara L, Sanches M, Cordeiro DC, Jackowski AP. Tranquilização rápida para pacientes agitados nos serviços de emergência psiquiátrica: um ensaio clínico randomisado de olanzapina, ziprasidona, haloperidol mais prometazina, haloperidol mais midazolam e haloperidol em monoterapia. Rev Bras Psiquiatr. 2011;33(1): 30-9.

Young SL, Taylor M, Lawrie SM. "First do no harm." A systematic review of the prevalence and management of antipsychotic adverse effects. J Psychopharmacol. 2015;29(4):353-62.

How to Cite
Silva, A. S. e, Inumaru, F. E., Vidor, R., Manoel, A. L., dos Santos, T., Carvalho, A. C., & Trevisol, D. J. (2016). Prevalence and profile of patients on antipsychotics in a hospital in southern Brazil. Scientia Medica, 25(4), ID21373.
Original Articles